Please login to the form below

Not currently logged in
Email:
Password:

Avidity Biosciences

This page shows the latest Avidity Biosciences news and features for those working in and with pharma, biotech and healthcare.

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Avidity Biosciences. ... Avidity's platform seeks to overcome the delivery challenges of oligonucleotides, RNA-targeting drugs which hold huge promise in reaching currently 'undruggable' targets.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...